Yang, J.; Xiong, X.; Zheng, W.; Liao, X.; Xu, H.; Yang, L.; Wei, Q.
Combining Novel Hormonal Therapies with a Poly (ADP-Ribose) Polymerase Inhibitor for Metastatic Castration-Resistant Prostate Cancer: Emerging Evidence. Curr. Oncol. 2023, 30, 10311-10324.
https://doi.org/10.3390/curroncol30120751
AMA Style
Yang J, Xiong X, Zheng W, Liao X, Xu H, Yang L, Wei Q.
Combining Novel Hormonal Therapies with a Poly (ADP-Ribose) Polymerase Inhibitor for Metastatic Castration-Resistant Prostate Cancer: Emerging Evidence. Current Oncology. 2023; 30(12):10311-10324.
https://doi.org/10.3390/curroncol30120751
Chicago/Turabian Style
Yang, Jie, Xingyu Xiong, Weitao Zheng, Xinyang Liao, Hang Xu, Lu Yang, and Qiang Wei.
2023. "Combining Novel Hormonal Therapies with a Poly (ADP-Ribose) Polymerase Inhibitor for Metastatic Castration-Resistant Prostate Cancer: Emerging Evidence" Current Oncology 30, no. 12: 10311-10324.
https://doi.org/10.3390/curroncol30120751
APA Style
Yang, J., Xiong, X., Zheng, W., Liao, X., Xu, H., Yang, L., & Wei, Q.
(2023). Combining Novel Hormonal Therapies with a Poly (ADP-Ribose) Polymerase Inhibitor for Metastatic Castration-Resistant Prostate Cancer: Emerging Evidence. Current Oncology, 30(12), 10311-10324.
https://doi.org/10.3390/curroncol30120751